{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:17:55Z","timestamp":1788200275086,"version":"build-2803163510"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High quality surveillance data are important to monitor changes in incidence and better understand risk factors for meningococcal disease. This report summarizes meningococcal disease epidemiology from 2020 through 2023 in the U.S.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Epidemiologic information and isolates obtained through Enhanced Meningococcal Disease Surveillance for meningococcal disease cases reported through the National Notifiable Diseases Surveillance System (NNDSS) during 2020\n                      <jats:bold>\u2013<\/jats:bold>\n                      2023 were included in the analysis. Isolates were characterized by serogrouping and molecular typing using whole genome sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1,192 confirmed and probable meningococcal disease cases were reported through NNDSS during 2020\u20132023. Incidence was highest in 2023 (0.13 cases per 100,000) and lowest in 2021 (0.06 cases per 100,000). The proportion of cases that were serogroup Y increased over time, accounting for 56.8% of cases in 2023 compared to 16.0% in 2021. For serogroup Y, the most common clonal complex (CC) was CC23 in 2020\u20132021 and CC174 in 2022\u20132023. Prior to 2022, CC174 was rare in the U.S., accounting for less than 10% of serogroup Y cases, but in 2022\u20132023, CC174 accounted for more than 60% of serogroup Y cases. Nine outbreaks began in 2020\u20132023 and included 109 cases. The proportion of cases associated with outbreaks ranged from 0.9% in 2020 to 26.2% in 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Meningococcal disease incidence continued to decline during the COVID-19 pandemic but increased to above pre-COVID-19 pandemic incidence by 2023. It will be important to continue to monitor meningococcal disease incidence, especially of serogroup Y, over the next several years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0356184","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:29:42Z","timestamp":1788197382000},"page":"e0356184","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Meningococcal disease epidemiology \u2013 United States, 2020\u20132023"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-6314","authenticated-orcid":true,"given":"Amy B.","family":"Rubis","sequence":"first","affiliation":[{"name":"Meningitis, Pertussis, and Diphtheria Epidemiology Branch","place":["Atlanta, Georgia, United States of America"],"department":["Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basanta R.","family":"Wagle","sequence":"additional","affiliation":[{"name":"Great Hill Solutions","place":["Atlanta, Georgia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Khuntia","sequence":"additional","affiliation":[{"name":"Applied Science Research and Technology","place":["Atlanta, Georgia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3651-8183","authenticated-orcid":true,"given":"Carolyn I.","family":"Wiest","sequence":"additional","affiliation":[{"name":"Applied Science Research and Technology","place":["Atlanta, Georgia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Shrestha","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention","place":["Atlanta, Georgia, United States of America"],"department":["Meningitis, Pertussis, and Diphtheria Laboratory Branch, Division of Bacterial Diseases"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-8699","authenticated-orcid":true,"given":"Vishakh","family":"Walia","sequence":"additional","affiliation":[{"name":"Great Hill Solutions","place":["Atlanta, Georgia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7145-899X","authenticated-orcid":true,"given":"Rebecca L.","family":"Howie","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention","place":["Atlanta, Georgia, United States of America"],"department":["Meningitis, Pertussis, and Diphtheria Laboratory Branch, Division of Bacterial Diseases"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8188-0323","authenticated-orcid":true,"given":"Sara L.","family":"Eisen","sequence":"additional","affiliation":[{"name":"Applied Science Research and Technology","place":["Atlanta, Georgia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4922-3787","authenticated-orcid":true,"given":"Brittney Z.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Applied Science Research and Technology","place":["Atlanta, Georgia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daya N.","family":"Marasini","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention","place":["Atlanta, Georgia, United States of America"],"department":["Meningitis, Pertussis, and Diphtheria Laboratory Branch, Division of Bacterial Diseases"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalabh","family":"Sharma","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention","place":["Atlanta, Georgia, United States of America"],"department":["Meningitis, Pertussis, and Diphtheria Laboratory Branch, Division of Bacterial Diseases"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"McNamara","sequence":"additional","affiliation":[{"name":"Meningitis, Pertussis, and Diphtheria Epidemiology Branch","place":["Atlanta, Georgia, United States of America"],"department":["Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"pone.0356184.ref001","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease. https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html Accessed 2024 April 16."},{"key":"pone.0356184.ref002","unstructured":"Centers for Disease Control and Prevention. 2019 Enhanced Meningococcal Disease Surveillance report. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/140466 Accessed February 7, 2025."},{"key":"pone.0356184.ref003","doi-asserted-by":"crossref","first-page":"735","DOI":"10.15585\/mmwr.mm6924a2","article-title":"Detection of Ciprofloxacin-Resistant, \u03b2-Lactamase\u2013Producing Neisseria meningitidis Serogroup Y Isolates \u2014 United States, 2019\u20132020","volume":"69","author":"LA McNamara","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"pone.0356184.ref004","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3201\/eid2503.181574","article-title":"University-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013-2018","volume":"25","author":"HM Soeters","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"pone.0356184.ref005","unstructured":"Otshudiema JO, Patton ME, DeMaria A. Risk factors for meningococcal disease among adults experiencing homelessness in Boston\u2014Massachusetts, 2016. In: 2017. https:\/\/cste.confex.com\/cste\/2017\/webprogram\/Paper7805.html"},{"key":"pone.0356184.ref006","volume-title":"Investigation of invasive meningococcal disease outbreak among the homeless community in Los Angeles County","author":"M Adeyemo","year":"2011"},{"issue":"5","key":"pone.0356184.ref007","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/cid\/cix438","article-title":"Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012-2015","volume":"65","author":"TA Folaranmi","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pone.0356184.ref008","unstructured":"Centers for Disease Control and Prevention. Risk Factors for Meningococcal Disease. https:\/\/www.cdc.gov\/meningococcal\/risk-factors\/index.html Accessed 2026 July 8."},{"key":"pone.0356184.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020","volume":"69","author":"SA Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"pone.0356184.ref010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jinf.2021.11.016","article-title":"Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review","volume":"84","author":"MR Alderson","year":"2022","journal-title":"J Infect"},{"issue":"6","key":"pone.0356184.ref011","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data","volume":"3","author":"AB Brueggemann","year":"2021","journal-title":"Lancet Digit Health"},{"key":"pone.0356184.ref012","article-title":"An increase in group B invasive meningococcal disease among adolescents and young adults in England following easing of COVID-19 containment measures","author":"SA Clark","year":"2022","journal-title":"SSRN Electron J"},{"issue":"7","key":"pone.0356184.ref013","article-title":"Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study","volume":"72","author":"K Huh","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0356184.ref014","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/infdis\/jiad028","article-title":"Changes in the incidence of invasive bacterial disease during the COVID-19 pandemic in the United States, 2014-2020","volume":"227","author":"N Prasad","year":"2023","journal-title":"J Infect Dis"},{"key":"pone.0356184.ref015","unstructured":"Sant\u00e9 publique France. Epidemiological situation of invasive meningococcal infections in France. 2022. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-a-prevention-vaccinale\/infections-invasives-a-meningocoque\/documents\/bulletin-national2\/situation-epidemiologique-des-infections-invasives-a-meningocoque-en-france.-point-au-31-decembre-2022"},{"issue":"12","key":"pone.0356184.ref016","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jiph.2023.10.001","article-title":"The rapid rebound of invasive meningococcal disease in France at the end of 2022","volume":"16","author":"S Taha","year":"2023","journal-title":"J Infect Public Health"},{"key":"pone.0356184.ref017","unstructured":"CDC. Meningococcal Disease (Neisseria meningitidis) 2015 Case Definition. https:\/\/ndc.services.cdc.gov\/case-definitions\/meningococcal-disease-2015\/ Accessed 2023 October 13."},{"key":"pone.0356184.ref018","unstructured":"Center for Disease Control and Prevention. Guidance for the Evaluation and Public Health Management of Suspected Outbreaks of Meningococcal Disease. http:\/\/www.cdc.gov\/meningococcal\/downloads\/meningococcal-outbreak-guidance.pdf Accessed 2023 October 1."},{"key":"pone.0356184.ref019","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. NCHS urban-rural classification scheme for counties. https:\/\/www.cdc.gov\/nchs\/data-analysis-tools\/urban-rural.html Accessed 2026 July 8."},{"issue":"6","key":"pone.0356184.ref020","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"MC Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0356184.ref021","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.601870","article-title":"Web-based genome analysis of bacterial meningitis pathogens for public health applications using the bacterial meningitis genomic analysis platform (BMGAP)","volume":"11","author":"SA Buono","year":"2020","journal-title":"Front Genet"},{"key":"pone.0356184.ref022","volume-title":"Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO manual","author":"World Health Organization, Centers for Disease Control and Prevention US","year":"2011","edition":"2"},{"issue":"11","key":"pone.0356184.ref023","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/infdis\/jiac046","article-title":"Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012\u20132016","volume":"225","author":"CC Potts","year":"2022","journal-title":"The Journal of Infectious Diseases"},{"key":"pone.0356184.ref024","unstructured":"National Center for Health Statistics. Bridged-race population estimates, United States. https:\/\/wonder.cdc.gov\/bridged-race-population.html 2023."},{"key":"pone.0356184.ref025","unstructured":"U.S. Census Bureau. Single-race population estimates, United States. https:\/\/wonder.cdc.gov\/single-race-population.html Accessed 2024 December 13."},{"key":"pone.0356184.ref026","doi-asserted-by":"crossref","first-page":"973","DOI":"10.15585\/mmwr.mm7343a3","article-title":"Statewide outbreak of Neisseria meningitidis serogroup Y, sequence type 1466 \u2014 Virginia, 2022\u20132024","volume":"73","author":"M Robinson","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"pone.0356184.ref027","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3201\/eid3004.231392","article-title":"Concurrent outbreaks of hepatitis A, invasive meningococcal disease, and mpox, Florida, USA, 2021-2022","volume":"30","author":"TJ Doyle","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"pone.0356184.ref028","unstructured":"Virginia Department of Health. Meningococcal Disease Outbreak Response. https:\/\/www.vdh.virginia.gov\/surveillance-and-investigation\/meningococcal-disease-outbreak-response\/ Accessed 2025 May 12."},{"issue":"8","key":"pone.0356184.ref029","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/cid\/cix993","article-title":"Current epidemiology and trends in meningococcal disease-United States, 1996-2015","volume":"66","author":"JR MacNeil","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0356184.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319940","article-title":"Enhanced surveillance for meningococcal disease-United States, 2015-2019","volume":"20","author":"AB Rubis","year":"2025","journal-title":"PLoS One"},{"issue":"4","key":"pone.0356184.ref031","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cid\/ciy548","article-title":"Epidemiology of Meningococcal Disease Outbreaks in the United States, 2009-2013","volume":"68","author":"SA Mbaeyi","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"pone.0356184.ref032","article-title":"Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study","volume":"2","author":"MJ Knol","year":"2017","journal-title":"Lancet Public Health"},{"key":"pone.0356184.ref033","article-title":"Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14","volume":"6","author":"A Funk","year":"2014","journal-title":"PLoS Curr"},{"key":"pone.0356184.ref034","article-title":"Invasive Meningococcal Meningitis Serogroup C Outbreak in Northwest Nigeria, 2015 - Third Consecutive Outbreak of a New Strain","volume":"8","author":"J Chow","year":"2016","journal-title":"PLoS Curr"},{"key":"pone.0356184.ref035","doi-asserted-by":"crossref","first-page":"14194","DOI":"10.1038\/s41598-018-32475-2","article-title":"Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria","volume":"8","author":"BA Kwambana-Adams","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0356184.ref036","first-page":"460","article-title":"Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019","volume":"30","author":"JF Kekeisen-Chen","year":"2024","journal-title":"Emerging Infectious Diseases"},{"key":"pone.0356184.ref037","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease. https:\/\/www.cdc.gov\/meningococcal\/php\/surveillance\/ Accessed 2025 May 2."},{"issue":"5","key":"pone.0356184.ref038","doi-asserted-by":"crossref","first-page":"99","DOI":"10.15585\/mmwr.mm7305a2","article-title":"Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance - United States, 2024","volume":"73","author":"I Berry","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:29:48Z","timestamp":1788197388000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356184"}},"subtitle":[],"editor":[{"given":"Mark","family":"McMillan","sequence":"first","affiliation":[{"name":"University of Adelaide School of Medical Sciences: The University of Adelaide Adelaide Medical School","place":["AUSTRALIA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0356184","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}